| Literature DB >> 22032513 |
Alexis C McCullough1, Melissa Seifried, Xiaochen Zhao, Jeffrey Haase, William J Kabat, Ram Yogev, Robert M Blumenthal, Deepa Mukundan.
Abstract
BACKGROUND: A six-fold increase in pediatric MRSA infections, prompted us to examine the clinical profile of children with MRSA infections seen at Mercy Children's Hospital, Toledo, Ohio and to characterize the responsible strains.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22032513 PMCID: PMC3216857 DOI: 10.1186/1471-2431-11-96
Source DB: PubMed Journal: BMC Pediatr ISSN: 1471-2431 Impact factor: 2.125
Figure 1Comparison of Pediatric MRSA Incidence in two time periods five years apart: June 1st to Dec 31st 2002 and 2007 (p < 0.0001).
Patient Characteristics
| n (%) | |
|---|---|
| Age group (years) | |
| 0-3 | 25 (43%) |
| 4-12 | 19 (33%) |
| 13-18 | 14 (24%) |
| Gender | |
| Female | 36 (62%) |
| Male | 22 (38%) |
| Race | |
| Caucasian | 16 (29%) |
| African American | 34 (62%) |
| Other | 5 (9%) |
| Type of Visit | |
| ER | 27 (47%) |
| Inpatient | 11 (19%) |
| Outpatient | 20 (34%) |
| Insurance | |
| Private | 6 (11%) |
| Medicaid | 43 (74%) |
| Uninsured | 9 (16%) |
| Preexisting Conditions | |
| SSTI | 24 (41%) |
| Respiratory Disease | 22 (38%) |
| Gastrointestinal | 9 (16%) |
| Cardiovascular | 3 (5%) |
| Nervous system | 1 (2%) |
| None | 19 (33%) |
| Site of Infection | |
| Face | 4 (7%) |
| Lower extremity | 18 (31%) |
| Perineal | 21 (36%) |
| Trunk | 4 (7%) |
| Upper extremity | 11 (19%) |
ER: Emergency room, SSTI: Skin and soft tissue infection
Associations with Age Group
| Age 0-3 N = 25 | Age 4-12 N = 19 | Age 13-18 N = 14 | Fisher's Exact Two-tailed P-value | |
|---|---|---|---|---|
| < 0.001 | ||||
| Face | 2 (8%) | 1 (5%) | 1 (7%) | |
| Lower extremity | 2 (8%) | 8 (42%) | 8 (57%) | |
| Perineal | 19 (76%) | 2 (11%) | 0 (0%) | |
| Trunk | 1 (4%) | 3 (16%) | 0 (0%) | |
| Upper extremity | 1 (4%) | 5 (26%) | 5 (36%) | |
| 7 (28%) | 9 (47%) | 6 (43%) | 0.42 | |
| 12 (48%) | 9 (47%) | 3 (21%) | 0.25 | |
| 19 (79%) | 14 (74%) | 9 (64%) | 0.59 | |
PFT: Pulse field type, SSTI: Skin and soft tissue infection
Figure 2USA300 PFT subtypes. This is a picture of the USA300 strains all run on a single gel and are labeled according to the PFT subtypes in Table 2, 3 & 4.
Molecular epidemiology of USA300 PFT strains (n = 58)
| USA300 PFT subtypes n(%) | Diversilab type* n(%) | SCC | ACME | |||
|---|---|---|---|---|---|---|
| USA300-41(98%) | 42 | IVa-42 | 42 | 42 | 30(71%) | |
| USA300-4(67%) | 6 | IVa-6 | 6 | 6 | 6 | |
| USA300-4 | 4 | IVa-4 | 4 | 4 | 4 | |
| USA300-2 | 2 | IVa-2 | 1 | 2 | 2 | |
| USA300-2 | 2 | IVa-2 | 2 | 2 | 2 | |
| USA300-1 | 1 | IVa-1 | 0 | 1 | 1 | |
| USA300-1 | 1 | IVa-1 | 1 | 1 | 1 | |
PFT: Pulsed field type; SCC: Staphylococcal Cassette Chromosome, lukSF-PV genes that encode Panton-Valentine leukocidin (PVL), ACME: Arginine catabolic mobile element.
*The DiversiLab strain types are named as corresponding PFT's based on a standardized comparison.
For USA300 PFT subtypes please see figure 2.
Associations with PFT Sub-type
| PFT Sub-type 1 N = 42 | PFT Sub-types 2-7 N = 16 | Fisher's Exact Two-tailed P-value | |
|---|---|---|---|
| Face | 2 (5%) | 2 (13%) | 0.35 |
| Lower extremity | 11 (26%) | 7 (43%) | |
| Perineal | 16 (38%) | 5 (31%) | |
| Trunk | 4 (10%) | 0 (0%) | |
| Upper extremity | 9 (21%) | 2 (13%) | |
| 15 (36%) | 7 (47%) | 0.54 | |
| 18 (43%) | 6 (40%) | 1.0 | |
PFT: Pulse field type, SSTI: Skin and soft tissue infection